- CEO
- De Shui Chen
- Full Time Employees
- 2,248
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- No.18, Huagong Road Quzhou ZH China 324302
- IPO Date
- Feb 9, 2021
- Business
- Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS) engages in the research, development, production and sale of functional polyols, starch sugars, rare sugars and dietary fiber worldwide, serving industries including confectionery, beverages, baking, dairy, personal care, pharmaceuticals and nutraceuticals. Founded in 1962 and headquartered at 18 Huagong Road, Huabu Town, Kaihua County, Quzhou, Zhejiang Province, China, the company operates as a national high-tech enterprise with subsidiaries such as Henan Jiaozuo Huakang Sugar Alcohol Technology Co., Ltd., Zhejiang Huakang Enterprises Co., Ltd., Zhejiang Huakang Pharma B.V. and Anhui Huayue Food Technology Co., Ltd., supporting an integrated raw material supply, production and sales system across China and global markets. Its core polyols portfolio includes xylitol for confectionery, baking, beverages and pharma; sorbitol for confectionery, seafood and personal care; maltitol for chocolate and baking; erythritol for beverages and nutraceuticals; lactitol for sugar-free candies and ice cream; mannitol for chewing gum and pharma; and isomalt for oral care and supplements; while starch sugars encompass high fructose syrup, glucose syrup, maltose syrup and maltodextrin for beverages, dairy and bakery; rare sugars feature D-xylose for pet food and flavors, L-arabinose for diabetic foods; and dietary fiber includes polydextrose for frozen foods and supplements. In recent developments, the company announced in October 2024 its intent to acquire 100% equity in Yusweet Co., Ltd. (also referred to as Yuxin Sugar Alcohol) for approximately CNY 1.098 billion through a mix of share issuance and cash, targeting enhanced xylitol production capacity and industry leadership; it also progresses a corn deep-processing project in Zhoushan and advances R&D collaborations, including a 2025 study on xylitol's gut microbiota benefits published with Zhejiang Gongshang University and COFCO.